Calmare

Dr. Selena Ellis of Berkeley California is proud to announce the first Neurology practice in the Western United States to offer Calmare therapy for the treatment of nerve pain. Dr. Ellis practices neurology at her medical practice which treats chronic pain in patients suffering from trigeminal neuralgia, peripheral neuropathy, Complex Regional Pain Syndrome (CRPS) and headache and migraines. After an in-depth evaluation process including the successful treatment of  chronic neuropathic pain with her patients, Dr. Ellis has added Calmare/Scrambler therapy.

Calmare is a FDA-cleared device which provides a non-invasive and non-narcotic therapy for the treatment of chronic neuropathic pain. Calmare therapy has also been very successful in achieving chronic pain relief for patients suffering from failed surgical back syndrome, Chemotherapy-induced Peripheral Neuropathy (CIPN) and other neuropathies. Significantly, there are no adverse side effects to this revolutionary therapeutic modality.

The Calmare technology employs electrostimulation that utilizes a low electrical current directed at the central nervous system through electrodes on the patient's skin surrounding the pain area. With the application of sixteen proprietary electrical impulse algorithms that are programmed to specifically target the body's C-fiber pathway (which transmits slower and chronic pain signals) versus the acute pain pathway, these electrical signals perform as artificial neurons to "re-program" the brain's receipt of the pain signal or message to offer long lasting pain relief instead of just "blocking" the pain message such as with transcutaneous electrical nerve stimulation (TENS).

 

No Cost First Treatment

Most patients who experience a reduction in pain after their first 45 minute treatment are deemed to have a high probability to achieve significant chronic pain relief after completion of a ten treatment regimen of 45 minute treatments. Patients interested in using Calmare will be offered the initial treatment at no cost to determine whether further treatments will have a high probability of reducing or eliminating their chronic pain. Patients must be weaned off certain medications before starting the therapy to achieve best effect.

Dr. Ellis says, “My practice focuses on providing chronic pain relief to my patients using the most safe, effective and non-addictive therapies available. As a neurologist, I am driven to be open to new promising modalities after conducting a complete evaluation of the patient. After seeing the positive results for relieving pain after using Calmare, I knew I wanted to be the first neurologist to offer the technology in the western US.”

 

About Selena Ellis, MD

Dr. Ellis attended medical school at the University of Washington in Seattle, Washington, and completed her neurology residency at the UCLA School of Medicine in 2002.  She obtained subspecialty training in electrodiagnosis of neuromuscular disease as Chief Resident and Fellow at the Wadsworth VA/UCLA Department of Neurology.

Dr. Ellis is board certified in both general neurology and electrodiagnostic medicine by the American Board of Psychiatry and Neurology (ABPN) and the American Board of Electrodiagnostic Medicine (AANEM) respectively. She is the current president and longtime board member of the San Francisco Neurological Society. Dr. Ellis is a pioneer in neurology with the first medical practice in Northern California to open an AANEM-certified electromyography (EMG) lab and the first neurologist in the western US to offer Calmare therapy.

Dr. Ellis treats common neurologic disorders such as headache, peripheral neuropathy, trigeminal neuralgia, occipital neuralgia, complex regional pain syndrome, back pain, and sciatica.  Other common symptoms in her practice include pain syndromes of many types, difficulty with gait or balance, and sensory changes to the arms or legs. Dr. Ellis also has subspecialty training in evaluation and management of problems affecting the peripheral nervous system, including systemic neuropathies, mononeuropathy and radiculopathy.

 

About Calmare/Scrambler Therapy

Distributed by Competitive Technologies, Inc. (OTCQX:CTTC), the Calmare® device (also known as Scrambler therapy) is a U.S. FDA 510(k)-cleared and European CE mark-certified pain therapy medical device for the non-invasive and non-narcotic treatment of chronic neuropathic and oncologic pain. Using a biophysical rather than a biochemical approach, Calmare employs a multi-processor able to simultaneously treat multiple pain areas by applying surface electrodes to the skin surrounding the area in pain. The device creates and relays a no-pain signal which becomes the dominant signal received by the brain, thereby overriding the pain signal and providing relief for the patient. The Calmare device has been used to successfully treat over 5,000 patients worldwide and has been shown to be effective in treating neuropathic and oncologic pain.